Patent · US Active

Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases

US8716288B2 · kind B2 · utility

2Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2013
Grant dateMay 6, 2014
Priority date
Expiry dateMay 10, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel pharmaceutical composition of benproperine derivatives for preventing and treating angiogenesis-related diseases. The benproperine derivatives and pharmaceutically acceptable salts thereof according to the present invention inhibit cancer cell migration and the angiogenesis of vascular endothelial cells, and therefore can be effectively used not only as an anticancer agent, but also as an agent for preventing and treating diseases caused by abnormal angiogenesis, such as diabetic retinopathy and corneal transplant rejection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.